Chicago (Aug. 14, 2002) -- Bob Basten, one of the pioneers in accounting industry consolidation, has stepped down as chief executive of Centerprise Advisors to concentrate on fighting Lou Gehrig's Disease.

Centerprise officials this morning disclosed that Basten, 42, was diagnosed in late July as having the disease, also known as ALS. Rick Stein, managing partner of Centerprise's Houston company, Mann Frankfort Stein & Lipp Advisors, has been appointed interim chief executive; Basten remains chairman.

Register or login for access to this item and much more

All Accounting Today content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access